Showing 9 of 9 recruiting trials for “Kawasaki disease”
Rivaroxaban for Children Aged Over 2 Years With Giant Coronary Artery Aneurysms After Kawasaki Disease
Kawasaki MATCH Trial
Enrolling by InvitationNCT06641843 ↗
Magnetic Resonance Myocardial Stress Perfusion in Pediatric Patients with Cardiovascular Disease
Model-informed Dose Optimization for Rivaroxaban in Children With Giant Coronary Artery Aneurysm After Kawasaki Disease
A Trial Comparing the Efficacy and Safety of Anakinra Versus Intravenous Immunoglobulin (IVIG) Retreatment, in Patients With Kawasaki Disease Who Failed to Respond to Initial Standard IVIG Treatment
Enrolling by InvitationNCT06641817 ↗
The Value of Cardiovascular Imaging in Kawasaki Disease
RecruitingNCT06993636 ↗
Pharmacometrics Analysis of Rivaroxaban in Chinese Children Aged Over 2 Years
RecruitingNCT06305611 ↗
European and North Indian Cohort of KaWasaki dIsease
Genome Analysis of Human Endogenous Retroviruses (HERVs)(COVID19)
👨⚕️ Marianna Fabi, MD, IRCCS Azienda Ospedaliero-Universitaria di Bologna📍 5 sites📅 Started Jun 2021View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →